Low serum glutathione peroxidase activity is associated with increased cardiovascular mortality in individuals with low HDLc's

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Buijsse, Brian ^a,b   Lee, Duk Hee ^a,e   Steffen, Lyn ^a   Erickson, Richard R ^c   Luepker, Russell V ^a   Jacobs, David R ^a,f   Holtzman, Jordan L ^c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Kyungpook National University School of Medicine   (South Korea)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; PHYSICAL ACTIVITY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84862488588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038901     Document Type: Article

References (28)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL, (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924.
2. Bowman TS, Bassuk SS, Gaziano JM, (2007) Interventional Trials of Antioxidants. In: Atherosclerosis, oxidant stress: a new perspective. In: Holtzman JL, editors. Editor. Atherosclerosis and Oxidant Stress: A New Perspective. New York: Springer, 25-50.
3. Holtzman JL, (2007) The role of glutathione pathways in the prevention of atherosclerosis. In: Holtzman JL, editors. Editor. Atherosclerosis and Oxidant Stress: A New Perspective. New York: Springer, 213-241.
4. McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ, (1992) Evidence for oxidative stress in unstable angina. Brit Heart J 68: 454-457.
5. Oen LH, Utomo H, Suyatna F, Hanafiah A, Asikin N, (1992) Plasma lipid peroxides in coronary heart disease. Int J Clin Pharmacol Ther Toxicol 30: 77-80.
6. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, et al. (2001) Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103: 1955-1960.
7. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, et al. (1992) Autoantibodies against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887.
8. Chen N, Liu Y, Greiner CD, Holtzman JL, (2000) Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med 136: 58-65.
9. Espinola-Klein C, Rupprecht HJ, Bickel C, Schnabel R, Genth-Zotz S, et al. (2007) AtheroGene Investigators. Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am J Cardiol 99: 808-812.
10. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, et al. (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349: 1605-1613.
11. Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, et al. (2007) Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38: 41-49.
12. Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J, (2004) Determinants of human plasma glutathione peroxides (GPx3) expression. J Biol Chem 279: 26839-26845.
13. Luepker RV, Jacobs DR, Gillum RF Folsom AR, Prineas RJ, (1985) Population risk of cardiovascular disease: the Minnesota Heart Survey. J Chronic Dis 38: 671-682.
14. Arnett DK, Jacobs DR Jr, Luepker RV, Blackburn H, Armstrong C, et al. (2005) Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 112: 3884-3891.
15. Arnett DK, McGovern PG, Jacobs DR Jr, Shahar E, Duval S, et al. (2002) Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am. J Epidemiol 156: 929-935.
16. Luepker RV, Arnett DK, Jacobs DR Jr, Duval SJ, Folsom AR, et al. (2006) Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med 119: 42-49.
17. Jacobs DR Jr, Ainsworth BE, Hartman TJ, Leon AS, (1993) A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc 25: 81-91.
18. National Heart Lung and Blood Institute. Lipid and lipoprotein analysis (1974) Manual of operations, Lipid Research Clinics Program. Vol 1. Bethesda, MD: National Heart, Lung, and Blood Institute. HEW Publication (NIH) pp. 75-628.
19. Warnick GR, Benderson J, Albers JJ, (1982) Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28: 1379-1388.
20. Maddipati KR, Marnett LJ, (1987) Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 262: 17398-17403.
21. Takahashi K, Avissar N, Whitin J, Cohen H, (1987) Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzymes. Arch Biochem Biophys 256: 677-686.
22. Lee D-H, Buijsse B, Steffen L, Holtzman JL, Luepker R, et al.Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil 16: 16-20.
23. Holtzman JL, (2002) The role of low levels of the serum glutathione-dependent peroxidase and glutathione and high levels of serum homocysteine in the development of cardiovascular disease. Clin Lab 48: 129-130.
24. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, et al. (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272: 17012-17017.
25. Porter M, Pearson DJ, Suarez-Mendez VJ, Blann AD, (1992) Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischaemic heart disease in man. Clin Sci (Lond) 83: 343-345.
26. Dogru-Abbasoglu S, Kanbagli O, Bulur H, Babalik E, Ozturk S, et al. (1999) Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem 32: 671-672.
27. Morrison JA, Jacobsen DW, Sprecher DL, Robinson K, Khoury P, et al. (1999) Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation 100: 2244-2247.
28. Cooney MT, Dudina A, D'Agostino R, Graham IM, (2010) Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 122: 300-310.